Research opportunities in brain cancers
Brain tumour survival remains low, and has changed little in over a generation. That's why we've made brain tumours a strategic priority as one of our four "cancers of unmet need".
We're boosting our investment into brain tumours, and we expect to spend around £25 million over the next five years on ring-fenced, targeted initiatives. We aim to expand our research portfolio across the research pipeline, and in all types of brain tumours, whether paediatric or adult.
We want to support the research that will make a real difference to people with brain tumours.
To do this, we need to build a dynamic, multidisciplinary research community in the UK through training, recruitment and by helping people in other fields shift their focus to brain tumour research.
We also want to develop the infrastructure required to facilitate innovation in the field, and create hubs of expertise.
Cancer Research UK Brain Tumour Conference
We'll be gathering world experts across a range of disciplines to discuss the latest advances in brain tumour research and how we can continue to drive forward progress.
Our events break the barriers between disciplines and open up new avenues for collaborative research. So save the date, and check back for more details closer to the time!
|1–3 May 2018|
|||Richard Gilbertson, Scientific Committee Chair
Luis F Parada, Keynote
Our extensive network of infrastructure provides state-of-the-art facilities, resources and platforms to support your research.
Our institutes provide an exceptional environment for discovery research. They include London's Francis Crick Institute, where cancer researchers collaborate with basic scientists in a variety of fields.
Our centres drive translational research collaborations at 13 locations. Our centres in Cambridge, Edinburgh, The Institute of Cancer Research and University College London have particular strengths in brain tumour research.
We also embrace the opportunities created by working closely with the UK's National Health Service, including access to cutting-edge clinical facilities such as proton beam.
We fund the best research from the best researchers, across the translational pipeline and the breadth of brain tumour types. The case studies below provide a taste of the kinds of projects and programmes that we currently support.